Papageorgiou, D.; Liouta, G.; Sapantzoglou, I.; Zachariou, E.; Pliakou, D.; Papakonstantinou, K.; Floros, T.; Pliakou, E.
HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions. Medicina 2024, 60, 2012.
https://doi.org/10.3390/medicina60122012
AMA Style
Papageorgiou D, Liouta G, Sapantzoglou I, Zachariou E, Pliakou D, Papakonstantinou K, Floros T, Pliakou E.
HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions. Medicina. 2024; 60(12):2012.
https://doi.org/10.3390/medicina60122012
Chicago/Turabian Style
Papageorgiou, Dimitrios, Galateia Liouta, Ioakeim Sapantzoglou, Eleftherios Zachariou, Dimitra Pliakou, Katerina Papakonstantinou, Theofanis Floros, and Evangelia Pliakou.
2024. "HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions" Medicina 60, no. 12: 2012.
https://doi.org/10.3390/medicina60122012
APA Style
Papageorgiou, D., Liouta, G., Sapantzoglou, I., Zachariou, E., Pliakou, D., Papakonstantinou, K., Floros, T., & Pliakou, E.
(2024). HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions. Medicina, 60(12), 2012.
https://doi.org/10.3390/medicina60122012
